Literature DB >> 19901194

Heart rate predicts outcomes in an implantable cardioverter-defibrillator population.

Mastaneh Ahmadi-Kashani1, David J Kessler, John Day, T Jared Bunch, Kira Q Stolen, Scott Brown, Salam Sbaity, Brian Olshansky.   

Abstract

BACKGROUND: Elevated heart rate (HR) is associated with adverse cardiovascular events and total mortality in the general population and in individuals with heart disease. Our hypothesis was that mean HR predicts total mortality and heart failure hospitalization in patients undergoing implantable cardioverter-defibrillator (ICD) implantation. METHODS AND
RESULTS: The Inhibition of Unnecessary RV Pacing With AV Search Hysteresis in ICDs (INTRINSIC RV) trial included 1530 patients undergoing ICD implantation. After implantation of a dual-chamber ICD, patients were followed for a mean of 10.4 months. The mean HR for 1436 patients over the follow-up period was determined from device histograms. Patients were grouped into strata by mean HR, and the relationship between the primary end point and mean HR was analyzed with Mantel-Haenszel ordinal chi(2) tests. Higher intrinsic (unpaced) HR was associated with greater risk of achieving the primary end point of death or heart failure hospitalization (P<0.001). Of patients with a mean HR <75 bpm, 5.8% died or were hospitalized for heart failure, whereas 20.9% with a mean HR >90 bpm achieved the same end point, a 3.6-fold difference (P<0.0001). In a multivariate model with the use of Cox regression, HR was a significant predictor with a hazard ratio of 1.34 (P=0.0001; 95% confidence interval, 1.19 to 1.50), as were age, New York Heart Association functional class, and percent right ventricular pacing, but it was independent of gender and beta-blocker dosing. When considered as continuous or discrete variables grouped by 5-bpm increments, HR remained a significant predictor.
CONCLUSIONS: In this ICD population, the mean intrinsic HR was strongly associated with outcomes. CLINICAL TRIAL REGISTRATION: http://www.clinicaltrials.gov. Identifier: NCT00148967.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19901194     DOI: 10.1161/CIRCULATIONAHA.108.847608

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

Review 1.  Role of heart rate as a marker and mediator of poor outcome for patients with heart failure.

Authors:  John R Kapoor; Paul A Heidenreich
Journal:  Curr Heart Fail Rep       Date:  2012-06

2.  Heart rate before ICU discharge: a simple and readily available predictor of short- and long-term mortality from critical illness.

Authors:  Wilhelm Grander; Kathrin Müllauer; Bernhard Koller; Herbert Tilg; Martin Dünser
Journal:  Clin Res Cardiol       Date:  2013-04-27       Impact factor: 5.460

Review 3.  Heart rate reduction in heart failure: ivabradine or beta blockers?

Authors:  Maya Guglin
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

Review 4.  Sinus Tachycardia: a Multidisciplinary Expert Focused Review.

Authors:  Kenneth A Mayuga; Artur Fedorowski; Fabrizio Ricci; Rakesh Gopinathannair; Jonathan Walter Dukes; Christopher Gibbons; Peter Hanna; Dan Sorajja; Mina Chung; David Benditt; Robert Sheldon; Mirna B Ayache; Hiba AbouAssi; Kalyanam Shivkumar; Blair P Grubb; Mohamed H Hamdan; Stavros Stavrakis; Tamanna Singh; Jeffrey J Goldberger; James A S Muldowney; Mark Belham; David C Kem; Cem Akin; Barbara K Bruce; Nicole E Zahka; Qi Fu; Erik H Van Iterson; Satish R Raj; Fetnat Fouad-Tarazi; David S Goldstein; Julian Stewart; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2022-09-08

5.  Pathophysiologic Insights into Heart Rate Reduction in Heart Failure: Implications in the Use of Beta-Blockers and Ivabradine.

Authors:  Takeshi Kitai; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02

6.  Prognostic value of resting heart rate on cardiovascular and renal outcomes in type 2 diabetic patients: a competing risk analysis in a prospective cohort.

Authors:  Aurelie Miot; Stéphanie Ragot; Wala Hammi; Pierre-Jean Saulnier; Philippe Sosner; Xavier Piguel; Florence Torremocha; Richard Marechaud; Samy Hadjadj
Journal:  Diabetes Care       Date:  2012-07-18       Impact factor: 19.112

7.  Serum albumin level and hospital mortality in acute non-ischemic heart failure.

Authors:  Arnaud Ancion; Sophie Allepaerts; Cécile Oury; Anne-Stephan Gori; Luc A Piérard; Patrizio Lancellotti
Journal:  ESC Heart Fail       Date:  2017-01-13

8.  Heart rate-adjusted PR as a prognostic marker of long-term ventricular arrhythmias and cardiac death in ICD/CRT-D recipients.

Authors:  Yu-Qiu Li; Shuang Zhao; Ke-Ping Chen; Yang-Gang Su; Wei Hua; Si-Lin Chen; Zhao-Guang Liang; Wei Xu; Yan Dai; Xiao-Han Fan; Shu Zhang
Journal:  J Geriatr Cardiol       Date:  2019-03       Impact factor: 3.327

Review 9.  The cardiosplenic axis: the prognostic role of the spleen in heart failure.

Authors:  Hiroaki Hiraiwa; Takahiro Okumura; Toyoaki Murohara
Journal:  Heart Fail Rev       Date:  2022-05-18       Impact factor: 4.654

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.